• 1. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

Professional Introduction to 2-Fluoro-3-iodo-5-(trifluoromethyl)pyridine (CAS No: 1207845-81-5)

2-Fluoro-3-iodo-5-(trifluoromethyl)pyridine, with the CAS number 1207845-81-5, is a highly versatile intermediate in modern chemical synthesis, particularly in the pharmaceutical and agrochemical industries. This compound features a pyridine core substituted with a fluoro group at the 2-position, an iodo group at the 3-position, and a trifluoromethyl group at the 5-position. These functional groups make it an attractive building block for constructing complex molecules with tailored biological activities.

The significance of this compound lies in its ability to serve as a precursor for the synthesis of various pharmacologically active agents. The presence of the fluoro and trifluoromethyl groups enhances the metabolic stability and lipophilicity of the final products, which are critical factors in drug design. Additionally, the iodo substituent allows for further functionalization via cross-coupling reactions, such as Suzuki-Miyaura or Stille couplings, enabling the introduction of diverse side chains and heterocycles.

In recent years, there has been growing interest in the development of novel therapeutic agents targeting various diseases, including cancer, infectious diseases, and neurological disorders. The compound 2-Fluoro-3-iodo-5-(trifluoromethyl)pyridine has emerged as a valuable scaffold in this context. For instance, researchers have leveraged its structure to design inhibitors of kinases and other enzymes involved in cancer progression. The electron-withdrawing nature of the trifluoromethyl group and the electron-donating effect of the fluoro group contribute to optimal binding affinities with biological targets.

The pharmaceutical industry has also explored derivatives of this compound for their potential antimicrobial properties. The combination of halogenated aromatic rings is known to disrupt bacterial cell membranes and interfere with essential metabolic pathways. Preliminary studies have shown that certain analogs exhibit promising activity against multidrug-resistant strains of bacteria, highlighting the therapeutic potential of this class of compounds.

Beyond pharmaceutical applications, 2-Fluoro-3-iodo-5-(trifluoromethyl)pyridine finds utility in agrochemical research. Its structural motifs are reminiscent of natural products that exhibit phytotoxic effects, making it a candidate for developing new herbicides or pesticides. The ability to modify its core structure allows chemists to fine-tune its biological activity, ensuring efficacy while minimizing environmental impact.

The synthesis of this compound typically involves multi-step organic transformations starting from commercially available pyridine derivatives. Key steps include halogenation at specific positions followed by protection-deprotection strategies to introduce the desired substituents. Advances in catalytic methods have streamlined these processes, making large-scale production more feasible and cost-effective.

In conclusion, 2-Fluoro-3-iodo-5-(trifluoromethyl)pyridine(CAS No: 1207845-81-5) is a cornerstone intermediate in synthetic chemistry with far-reaching implications in drug discovery and agricultural science. Its unique structural features enable the construction of complex molecules with high biological potency, making it indispensable in modern medicinal chemistry. As research continues to uncover new applications for this compound, its importance is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)